2015 Feb 4. pii: S0960-894X(15)00085-2. doi: 10.1016/j.bmcl.2015.01.064. [Epub ahead of print]
Abstract
We report the design and synthesis of novel prostaglandin-ethanolamide (PGE2-EA) analogs containing head and tail group modifications to aid in the characterization of a putative prostamide receptor(s). Our synthetic approach utilizes Horner-Wadsworth-Emmons and Wittig reactions to construct the head and the tail moieties of the key PGE2 precursor, which leads to the final products through a peptide coupling, Swern oxidation and HF/pyridine assisted desilylation. The synthesized analogs were shown not to interact significantly with endocannabinoid proteins and recombinant EP1, EP3 and EP4 receptors and suggest a yet to be identified prostamide receptor as their site(s) of action.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Copyright © 2015 Elsevier Ltd. All rights reserved.
KEYWORDS:
Cyclooxygenase-2; Endocannabinoids; Prostamides
- PMID:
- 25701254
- [PubMed – as supplied by publisher]